Related references
Note: Only part of the references are listed.Mechanism of Acid Hypersecretion Post Curative Gastrinoma Resection
Jeremiah V. Ojeaburu et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms
Stefano La Rosa et al.
HUMAN PATHOLOGY (2011)
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich-Frank Pape et al.
CANCER (2008)
Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis
R. HÅKANSON et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: Identification of risk factors
Marc J. Berna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
RASSFIA promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours
S Pizzi et al.
JOURNAL OF PATHOLOGY (2005)
Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors
T D'Adda et al.
MODERN PATHOLOGY (2005)
Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment
JA Norton et al.
SURGERY (2004)
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas
PL Peghini et al.
GASTROENTEROLOGY (2002)
Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours
S Pizzi et al.
JOURNAL OF PATHOLOGY (2002)
Different patterns of 11q allelic losses in digestive endocrine tumors
T D'Adda et al.
HUMAN PATHOLOGY (2002)
Share Paper
